决策树区分伴黏液特征的肺腺癌与转移性结直肠腺癌
研究基于切除标本中CK7、TTF-1、NapsinA、CK20、CDX2和SATB2的染色特征,构建了基于TTF-1、SATB2、CDX2和CK7的决策树,用于区分伴黏液特征的肺腺癌与转移性结直肠腺癌。在肺和肺引流淋巴结的FNA标本中验证,肺标本一致率84%,淋巴结标本一致率100%;算法指定原发部位时与多学科诊断准确率95%。
要点
- 决策树基于TTF-1、SATB2、CDX2和CK7,可区分肺原发黏液腺癌与结直肠转移。
- FNA验证中肺标本一致率84%,淋巴结标本一致率100%。
- 算法指定原发部位时与多学科诊断准确率95%。
核心结论
- 基于TTF-1、SATB2、CDX2和CK7的决策树在切除、活检和FNA标本中有望区分肺原发与转移性黏液腺癌。
研究设计与样本
- 作者检查了伴黏液特征的肺腺癌和转移性结直肠腺癌切除标本中CK7、TTF-1、NapsinA、CK20、CDX2和SATB2的染色特征与异质性。
主要发现
- 基于队列中异质性、敏感性和特异性,作者构建了基于TTF-1、SATB2、CDX2和CK7的决策树。
- 在肺和肺引流淋巴结FNA标本中验证,肺标本一致率84%,淋巴结标本一致率100%。
- 算法指定原发部位时与多学科诊断准确率95%。
关键数值与推荐
- 决策树使用TTF-1、SATB2、CDX2和CK7将肿瘤分类为原发或转移。
- FNA验证肺标本一致率84%,淋巴结标本一致率100%,指定原发部位准确率95%。
临床怎么用
- 该决策树可辅助病理医生在切除、活检和FNA标本中区分肺原发黏液腺癌与结直肠转移。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diagnosis of mucinous carcinomas in the lung on transbronchial biopsy or fine-needle aspiration (FNA) samples can be difficult for the pathologist, because primary and metastatic tumors can have similar morphological, immunohistochemical, and molecular characteristics. Correct diagnosis is key to determine appropriate therapy and to distinguish primary from metastatic disease. This distinction often falls to the pathologist in patients with a history of mucinous adenocarcinoma of the colon. Despite its drawbacks, immunohistochemistry is often employed to help assign a primary site for mucinous adenocarcinomas in the lung. However, the published data in this regard is limited to studies that use only a handful of markers. METHODS: The authors examined the staining characteristics and heterogeneity of CK7, TTF-1, NapsinA, CK20, CDX2, and SATB2 in resection specimens of pulmonary adenocarcinomas with mucinous features and metastatic colorectal adenocarcinoma. RESULTS: Based on the heterogeneity, sensitivity, and specificity in this cohort, the authors developed a decision tree based on TTF-1, SATB2, CDX2, and CK7 to categorize tumors as primary or metastatic lesions. Validation of the decision tree in FNA specimens from the lungs and lung-draining lymph nodes showed 84% concurrence in cases from the lung and 100% concurrence in cases from the lymph node. In cases where the algorithm assigned a primary site, it was 95% accurate compared to the multidisciplinary diagnosis. CONCLUSIONS: This method holds promise in distinguishing primary versus metastatic lesions in resection, biopsy, and FNA samples from the lungs.
引用
- Wein AN, Lin CY, Ritter JH, et al. Development and validation of a decision tree for distinguishing pulmonary adenocarcinomas with mucinous features and metastatic colorectal adenocarcinoma. Cancer Cytopathol. 2023. PMID: 37676090. doi:10.1002/cncy.22758
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。